🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of blood and/or tissue in the laboratory from p...
Status
Completed
Location
Addenbrooke's Hospital
Start Date
2007-07
Trial ID
NCT00900536
RATIONALE: Studying proteins in head and neck cancer cells in the laborator...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2005-05
Trial ID
NCT00896948
In addition to a medical history and clinical examination, the diagnosis of...
Status
Recruiting
Location
University Hospital of Bonn
Start Date
2021-10-10
Trial ID
NCT05132348
Treatments Being Tested
RATIONALE: Bafetinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
City of Hope Medical Center
Start Date
2010-12
Trial ID
NCT01234740
The purpose of the study is to research the association between receiving T...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2012-07
Trial ID
NCT01626248
RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-05
Trial ID
NCT00686218
RATIONALE: Studying the effects of obatoclax mesylate in cell samples from ...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01150656
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Terminated
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2007-02
Trial ID
NCT00899132
Treatments Being Tested
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
The study will reveal the transcriptomic signature linked to the aberrant a...
Status
Unknown
Location
Division of Clinical Immunology, Fondazione Policlinico Universitario A. Gemelli-IRCCS
Start Date
2021-07-29
Trial ID
NCT05754112
Treatments Being Tested